LeadIQ logo
Learn more at LeadIQ.com

Insights

T Cell Therapies Immatics focuses on developing innovative T cell therapies for cancer immunotherapy, offering a new avenue for potential collaborations and partnerships in the oncology market.

Recent Funding Recent financing rounds of $150 million and $175 million indicate strong investor confidence, presenting an opportunity for financial institutions or investors looking to engage with a growing biotech company like Immatics.

Expansion into mRNA Therapeutics Immatics' venture into mRNA-based therapeutics in partnership with industry players signifies an emerging area of growth, presenting a potential sales opportunity for companies specializing in mRNA technology.

Strategic Collaborations Strategic collaborations with renowned names like Moderna, CytomX, and Personalis demonstrate Immatics' commitment to cutting-edge therapies, opening doors for companies seeking to align with leaders in the biotechnology sector.

Board of Directors Appointment The addition of industry expert Alise Reicin to Immatics' Board of Directors signals a focus on strong leadership and strategic direction, offering networking opportunities for organizations seeking partnerships with key decision-makers.

Similar companies to Immatics

Immatics Tech Stack

Immatics uses 8 technology products and services including SAP, NetApp, Veeva Vault, and more. Explore Immatics's tech stack below.

  • SAP
    Customer Relationship Management
  • NetApp
    Data Management
  • Veeva Vault
    Enterprise Content Management
  • Dell
    IT Infrastructure
  • jQuery Mobile
    Mobile Frameworks
  • Microsoft Azure
    Platform As A Service
  • Python
    Programming Languages
  • C++
    Programming Languages

Media & News

Immatics's Email Address Formats

Immatics uses at least 1 format(s):
Immatics Email FormatsExamplePercentage
First.Last@immatics.comJohn.Doe@immatics.com
60%
Last@immatics.comDoe@immatics.com
33%
First.Last@immatics.comJohn.Doe@immatics.com
5%
First@immatics.comJohn@immatics.com
2%

Frequently Asked Questions

Where is Immatics's headquarters located?

Minus sign iconPlus sign icon
Immatics's main headquarters is located at Paul-Ehrlich-Str. 15 Tuebingen, 72076 DE. The company has employees across 3 continents, including EuropeNorth AmericaSouth America.

What is Immatics's phone number?

Minus sign iconPlus sign icon
You can contact Immatics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Immatics's stock symbol?

Minus sign iconPlus sign icon
Immatics is a publicly traded company; the company's stock symbol is IMTX.

What is Immatics's official website and social media links?

Minus sign iconPlus sign icon
Immatics's official website is immatics.com and has social profiles on LinkedIn.

How much revenue does Immatics generate?

Minus sign iconPlus sign icon
As of November 2024, Immatics's annual revenue reached $75M.

What is Immatics's SIC code NAICS code?

Minus sign iconPlus sign icon
Immatics's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Immatics have currently?

Minus sign iconPlus sign icon
As of November 2024, Immatics has approximately 537 employees across 3 continents, including EuropeNorth AmericaSouth America. Key team members include Chief Medical Officer: C. M. B.Chief Financial Officer: A. C.Chief Financial Officer: D. M.. Explore Immatics's employee directory with LeadIQ.

What industry does Immatics belong to?

Minus sign iconPlus sign icon
Immatics operates in the Biotechnology Research industry.

What technology does Immatics use?

Minus sign iconPlus sign icon
Immatics's tech stack includes SAPNetAppVeeva VaultDelljQuery MobileMicrosoft AzurePythonC++.

What is Immatics's email format?

Minus sign iconPlus sign icon
Immatics's email format typically follows the pattern of . Find more Immatics email formats with LeadIQ.

When was Immatics founded?

Minus sign iconPlus sign icon
Immatics was founded in 2000.
Immatics

Immatics

Biotechnology ResearchTuebingen, Germany501-1000 Employees

Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies and TCR Bispecifics as well as our partnerships with global leaders in the pharmaceutical industry. We are committed to delivering the power of T cells and to unlocking new avenues for patients in their fight against cancer.

Read more about Immatics on our homepage: https://immatics.com/

Find us also on:
Twitter: https://twitter.com/immatics
Instagram: https://www.instagram.com/immatics/
YouTube: https://www.youtube.com/channel/UCv7uTpsGXvSNzwSX_xOtYSA

Legal notice: https://immatics.com/imprint/

Section iconCompany Overview

Headquarters
Paul-Ehrlich-Str. 15 Tuebingen, 72076 DE
Phone number
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
IMTX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2000
Employees
501-1000

Section iconFunding & Financials

  • $50M$100M

    Immatics's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $50M$100M

    Immatics's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.